Thoracocardiography. Part 2: Noninvasive measurement of changes in stroke volume; comparisons to impedance...

The thoracocardiograph (TCG) displays cardiac oscillations transmitted to the external surface of the thorax through inductive plethysmographic transducers placed transversely around the thorax near or about the xiphoid process. Such signals, with the appearance of ventricular volume curves, were used to compute changes of stroke volume (SV) and cardiac output (CO) in normal subjects. Their values were compared with changes of SV and CO measured with the impedance cardiograph (IC). Increases of SV and CO were produced with subcutaneous terbutaline and there was excellent agreement between TCG and IC values, best from TCG transducers placed at the xiphoid process and 3 cm caudal to it, although TCG locations 6 cm caudad and 3 cm cephalad to the xiphoid were also satisfactory. Since the site 3 cm caudad to the xiphoid process is known to anatomically transect solely a segment of the left ventricle, it was designated the TCG-Reference location. Both TCG and IC derived SV were not altered during postural shifts about a horizontal axis. Neither TCG nor IC showed the expected large decreases of SV from supine posture to head-up tilt. With baseline TCG and IC measurements in 60 degrees head-up tilt. MAST suit application increased CO measured with TCG but not with IC. Neither TCG nor IC revealed alteration of CO with nasal CPAP up to 10 cm H2O despite a rise in functional residual capacity (FRC) level of 870 ml. This investigation indicates that TCG has promise as a near continuous, noninvasive monitor of SV and CO in normal subjects if postural axis is fixed and does not require highly trained personnel or labor-intensiveness for its operation.